Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe!! 0.0022 0.0024 going back up
ONCP 0.0025- 0.0029 crazy lol
ONCP 0.0024 - 0.0025
ONCP Huge volume! 0.0023- 0.0024
Playing ONCP FWIW
A little dip,then we should go back up imho
BIEL going back up
ASFX 0.0135- 0.0140 might dip a little here!
ASFX 0.0110 - 0.0120
BIEL keeps u/t 0.0096- 0.0097 Break out!
BIEL 0.0095 getting hit :)
BIEL 0.0094- 0.0095
ASFX 0.0080 - 0.0083
Took this Snapshot of BIEL L2:
BIEL L2 look real thin >>>
BIEL 0.0090 - 0.0095 , Gapping up on yesterday's FDA filling & upcoming CC
BIEL 0.0090- 0.0095 now ,My Next Pennyland Play!
BIEL L2 look real thin >>>Snapshot
BIEL (1)X 0.0084 -(1)X 0.0085
BIEL 0.0084- 0.0085 up 82%,Going to 0.01+! imo>>
Yesterday June 15,The company has announced it is filing an application with the U.S. Food and Drug Administration ( FDA ) for 510(k) clearance to market its Allay(TM) Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
Also BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, yesterday announced its management team will host an investor conference call to discuss its recent application for FDA clearance, the status of clinical trials and additional FDA filings planned over the coming few months. The call will be held on Thursday, June 18th , at 4:15 PM (EDT) .
On the call, Barry Eppley , MD, DMD will review the findings of the recently published study on the Allay Period Relief Patch for the treatment of dysmenorrhea. Additionally, Sheena Kong , MD, will discuss the commencement of a new clinical study on the use of ActiPatch for the treatment of lower back pain. The lower back pain study is expected to be one of the largest studies on lower back pain ever conducted.
To access the conference call, please dial (712) 432-0080 approximately 10 minutes prior to the start time and enter access code 404367# to be placed into the conference.
BIEL 0.0084- 0.0085 up 82%,Going to 0.01+! imo>>
Yesterday June 15,The company has announced it is filing an application with the U.S. Food and Drug Administration ( FDA ) for 510(k) clearance to market its Allay(TM) Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
Also BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, yesterday announced its management team will host an investor conference call to discuss its recent application for FDA clearance, the status of clinical trials and additional FDA filings planned over the coming few months. The call will be held on Thursday, June 18th , at 4:15 PM (EDT) .
On the call, Barry Eppley , MD, DMD will review the findings of the recently published study on the Allay Period Relief Patch for the treatment of dysmenorrhea. Additionally, Sheena Kong , MD, will discuss the commencement of a new clinical study on the use of ActiPatch for the treatment of lower back pain. The lower back pain study is expected to be one of the largest studies on lower back pain ever conducted.
To access the conference call, please dial (712) 432-0080 approximately 10 minutes prior to the start time and enter access code 404367# to be placed into the conference.
Good start for BIEL IMO
who doesn't lol
Yeah!
Nice list ,let's see how it goes !
WNBD-BIEL-BEHL -ASFX-HTDS .....
Gonna be a busy day bud!gltya
GM buddy $$$$$ ;)
BIEL Watch this stock fellows,Going to be an interesting play!JMHO
NEWS for an investor conference call to discuss its recent application for FDA clearance
Monday, June 15 2009 3:51 PM, EST BioElectronics Announces Investor Conference Call Market Wire "US Press Releases "
FREDERICK, MD -- (MARKET WIRE) -- 06/15/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced its management team will host an investor conference call to discuss its recent application for FDA clearance, the status of clinical trials and additional FDA filings planned over the coming few months. The call will be held on Thursday, June 18th , at 4:15 PM (EDT) .
On the call, Barry Eppley , MD, DMD will review the findings of the recently published study on the Allay Period Relief Patch for the treatment of dysmenorrhea. Additionally, Sheena Kong , MD, will discuss the commencement of a new clinical study on the use of ActiPatch for the treatment of lower back pain. The lower back pain study is expected to be one of the largest studies on lower back pain ever conducted.
To access the conference call, please dial (712) 432-0080 approximately 10 minutes prior to the start time and enter access code 404367# to be placed into the conference.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (http://www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: For media enquiries, please contact: Joe Noel BioElectronics Corp. (925) 922-2560
Awesome calls TAKI :)
Congrats everyone :) Tomorrow's another day $$$$$
BIEL CHART >>The Next Penny Mover ...
BIEL NEWS ALERT >>> Posted by: WiseTrader Date: Monday, June 15, 2009 11:05:41 AM
In reply to: None Post # of 1506064
BIEL FDA NEWS:
Monday, June 15 2009 11:00 AM, EST BioElectronics Is Filing for 510(k) Clearance With FDA for Its Allay(TM) Product Market Wire "US Press Releases "
FREDERICK, MD -- (MARKET WIRE) -- 06/15/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it is filing an application with the U.S. Food and Drug Administration ( FDA ) for 510(k) clearance to market its Allay(TM) Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
"While between 60% and 70% of women suffer from pain during menstruation, with millions of women experiencing pain severe enough to significantly restrict daily activities, there are very few safe alternatives for pain relief," commented Andrew Whelan , CEO of BioElectronics, Corp. "The most widely used treatment for dysmenorrheal is acetaminophen, but it is also the leading causes of liver failure in the U.S(1). The Allay Menstrual Pain Relief Patch offers a far safer, highly effective and drug-free solution for millions of women who suffer from period pain and cramps. We are excited to bring this product to market."
The Allay Menstrual Pain Relief Patch is based on Pulsed Electromagnetic Field (PEMF) therapy, which is proven safe and effective in hundreds of peer reviewed clinical studies. Using advance semiconductor and micro-battery technologies, BioElectronics has achieved a technological breakthrough in shrinking PEMF technology into a very small form factor that has been packaged into a wafer thin patch that can be worn directly on the skin. The product is currently available over the counter in most counties outside of the United States . The filing with the FDA , is designed to make this drug-free pain relieving technology widely available to women within the United States .
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (http://www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
(1) Source reference: Larson AM et al, Acetaminophen-Induced Acute Liver Failure: Results a United States Multicenter, Prospective Study. HEPATOLOGY 2005;42:1364-1372
Tylenol is a registered Trademark of McNEIL-PPC, Inc.
Contact: For media enquiries, please contact: Joe Noel BioElectronics Corp. (925) 922-2560
-----------------------------------------
-----------------------------------------
PersonMarke me ,Click here :)
Thanks
http://investorshub.advfn.com/boards/addPersonMrk.asp?user=121377
Sweet,Let's see 0.01 + tomorrow :)
BIEL 0.0084 - 0.0085 up 82.61%,who's playing this monster with me ?GLTYA
BIEL 0.0083 - 0.0084 @ HOD Tomorrow's gapper
BIEL Large blocks @ ask
BIEL 800K @ ask :)
BIEL 0.0083 - 0.0084
BIEL 0.0081 - 0.0084 We might close 0.0090 !!!!
biel 0.0081 - 0.0082
BIEL 0.0079 - 0.0082 UP 78% gapper....